Sparassis crispa (Hanabiratake) is a widely used medicinal mushroom in traditional Chinese medicine because it contains materials with pharmacological activity. Here, we report its 39.0-Mb genome, encoding 13,157 predicted genes, obtained using next-generation sequencing along with RNA-seq mapping data. A phylogenetic analysis by comparison with 25 other fungal genomes revealed that S. crispa diverged from Postia placenta, a brown-rot fungus, 94 million years ago. Several features specific to the genome were found, including the A-mating type locus with the predicted genes for HD1 and HD2 heterodomain transcription factors, the mitochondrial intermediate peptidase (MIP), and the B-mating type locus with seven potential pheromone receptor genes and three potential pheromone precursor genes. To evaluate the benefits of the extract and chemicals from S. crispa, we adopted two approaches:
Analysis of mating type loci. Two mating type loci, A and B, were identified in the genome sequence of S. crispa on different contigs ( Fig. 3 ; Table S5 ). The A-mating-type locus was identified by homology search with the genes for HD1 and HD2 homeodomain transcription factors, and the mitochondrial intermediate peptidase (MIP) of Coprinopsis cinerea and Schizophyllum commune, where relatively high protein homologies (66~67% identity) were found for MIP, but low homologies (28~34% identity) were found for HD1 and HD2. However, all three genes were found to be located in close proximity on the same contig (contig 1), and there is similarity in the arrangement of HD1 and HD2 genes (located on different strands but with the characteristic outward transcriptional direction) compared with other fungi 20 , suggesting them to be functional. On the other hand, we found a total of seven potential pheromone receptor genes and three potential pheromone precursor genes for the B-mating-type locus, which were mapped on contig 10 ( Fig. 3 ; Table S5 ).
CAZymes and glycosyltransferases (GTs).
A total of 246 candidate carbohydrate-active enzyme genes (CAZymes) were identified in the genome of S. crispa, which included 131 glycoside hydrolases (GHs), 10 carbohydrate esterases (CEs), 61 glycosyl transferases (GTs), 4 polysaccharide lyases (PLs), 19 carbohydrate-binding modules (CBMs) and 31 auxiliary activity enzymes (AAs) ( Table S6 ). The distribution of CAZymes in S. crispa was compared with 25 other fungi. Compared with the genomes of Agaricales, Polyporales generally had fewer CAZymes, and S. crispa had the lowest number of GHs among them (Table S6 ). The variety of GTs ( Fig. 4 ; Table 2 ) and GHs ( Fig. S1 ; Table 2 ) of S. crispa was compared with those of Phanerochaete chrysosporium 21 , Postia placenta 18 and Lentinula edodes 14 . Compared with other fungi, S. crispa had the lowest number of genes in each category of CAZymes, and S. crispa, or the group containing S. crispa, had the lowest number of GT family genes of GT1, GT5, GT17, GT69 and GT90 (Table S6 ; Fig. 4 ). On the other hand, S. crispa had a low number of GH family genes (about half of that in Lentinula edodes), and thus, many GH families had the lowest numbers compared with three other fungi (Table S6 ; Fig. S1 ). Thus, S. crispa may be classified as a fungus with poorly developed carbohydrate utilization ability.
Identification of β-glucan synthases. Among polysaccharides in the fungal cell wall, β-1,3-glucan (β-glucan) is the most prevalent and has been widely used for pharmacological purposes. β-Glucan is synthesized from uridine 5'-diphosphate (UDP)-glucose by β-glucan synthase. β-Glucan synthase is a membrane protein composed of catalytic domains and transmembrane domains. In Saccharomyces cerevisiae, there are two independent 589  590  5 91 592 593  594  595  596  597  5 98  599 600  601   602 603 604  605   606  607  608  609 610  611   279 2 80   303   302  301  300  299  298  297  296  295  294  293  292  291  290  289   288   287  286  285  284  283  282  281  304   305   305 MatA locus MatB locus β-glucan synthase genes (FKS1 and FKS2). Identification of β-glucan synthase genes was performed by BLASTP search with reported genes (see Materials and Methods), where we found two potential β-glucan synthase genes, ScrFKS1 and ScrFKS2, which are homologous to type I and type II genes, respectively (Table S7 ; Fig. 5 ). The presence of these two different types is a common characteristic of Agaricomycetes mushrooms 22 . ScrFKS1 and ScrFKS2 are homologous to the previously reported type I and type II genes by 77-90% or 77-92%, respectively (Table S7) , thereby indicating these to be new genes. Two regions, a region homologous to the catalytic domain of FKS1 23 and a β-glucan synthase-homologous region, were identified in both genes by Pfam database search, and transmembrane domains by TMHMM database search (Figs 5 and S2). Although two transmembrane domains, TM1 and TM2, are present at identical positions, they differ in that the region between TM1 and TM2 is localized outside the cell in ScrFKS1 but inside in ScrFKS2. In addition, there are several potential N-glycosylation sites, some of which are well-conserved between them ( Biosynthetic gene clusters. Other than highly-polymerized structure of β-glucan, small molecules or secondary metabolites, such as terpenes, indoles and polyketides, have been known to act as bioactive compounds, and the genes responsible for their synthesis are known to form clusters 15, 25 . A total of 15 such gene clusters were identified in the S. latifolia genome, among which the genes encoding terpene synthase for the synthesis of mono-, sesqui-, and di-terpenes, indole prenyltransferase (indole-PTase) or dimethylallyl tryptophan synthase (DMATS) for the synthesis of indole alkaloids, and type I polyketide synthases for the synthesis of aromatic and highly reduced polyketide metabolites, were respectively found 17 . Meanwhile, a total of 30 gene clusters were identified here in the S. crispa genome ( Fig. S3 ), which include 15, 2, 5 and 8 genes potentially associated with the synthesis/metabolism of terpenes, indoles, polyketides and others, respectively (summarized in Table S8 ). Note that all these chemical categories have been known to include chemicals with estrogenic activity and that some are derived from fungi, such as zearalenone and brefeldin A 26 . Thus, we next tried to find chemicals with estrogenic activity in the extract of S. crispa.
Estrogenic activity associated with the mycelial extract. We then examined whether the water extract of S. crispa (SCE) contains beneficial components by screening for silent estrogens, which has been reported for an edible mushroom Agaricus blazei (A. blazei) 27 . A silent estrogen is a category of chemicals that exhibit estrogenic gene expression profiles but do not have any growth-stimulating activity in estrogen-responsive breast cancer MCF-7 cells, and thus may be beneficial for preventing cancer progression and as alternatives for estrogen antagonists 28 . SCE did not exhibit any growth-stimulating activity in MCF-7 cells (Fig. 6a ), but it rapidly activated both Erk1/2 and Akt ( Fig. 6c ), which are markers of the non-genomic pathway of estrogen signaling 29 . We also examined whether the activity was retained after extraction of SCE with ethylacetate ( Fig. 6b) , which was the case for A. blazei 30 . No estrogenic activity was detected by DNA microarray-based gene expression profiling for the ethylacetate extract (R = 0.04, Fig. 6d ), but SCE had profiles (R = 0.76 for SCE10 or 0.62 for SCE100) comparable with that for 17β-estradiol (E 2 ) (R = 0.81). As SCE contained very small amounts of β-glucans (0.95% of the amount in the dry mycelium, data not shown), the chemical(s) responsible for estrogenic activity may be a water soluble chemical with a low molecular weight.
Discussion
S. crispa is a brown-rot fungus that grows primarily on the stumps of coniferous trees, and is widely distributed throughout the North Temperate Zone 2 . S. crispa has been known as a source of natural products with bioactive properties, such as for nutraceutical 31 , medicinal 32, 33 and cosmetic 34 applications. Among compounds found in S. crispa, β-glucan has been extensively studied as chemicals effective for neuroprotection 35 , cardioprotection 36 and anti-inflammation 37 . In contrast, recent studies showed that the aromatic compounds isolated from S. crispa are effective for the treatment of cancer 38 or hyperlipidemia 39 . Here, we used the mycelium of S. crispa (strain Scrmy26) as a source both for the genome/gene analysis and the analysis of bioactive materials to employ a consistent system for the analyses. We focused on the mycelium here because controlling the culture conditions would be easier and thus mass production and quality control could be standardized. Furthermore, S. crispa is one of the mushrooms that contain the highest phenolic contents and the highest antioxidant capacity in mycelia 40 . The analysis of the S. crispa genome revealed its relatively high GC% (51.4%; Table 1 ) among the 26 fungal genomes compared here, while the sizes of the genome and the number of protein-coding genes are well within their variations. From the phylogenetic analysis, S. crispa was likely diverged from Postia placenta 94 MYA. Both S. crispa and P. placenta belong to brown-rot fungi, which degrade plant cell walls by ligninolysis with distinct differences from while-rot fungi including the mechanism of lignocellulose conversion 18 . The numbers of categories of CAZyme genes, such as GHs and GTs, are comparable between them (131 GHs for S. crispa and 144 GHs for P. placenta, or 61 GTs for S. crispa and 65 GTs for P. placenta; Table S6 ), suggesting similarity in their lifestyle evolutions 41 . As the classification of fungi has often been controversial and, several revisions have resulted in several taxonomic synonyms for P. placenta 42 , it will be quite informative to find the similarity as well as the differences in genome sequences between these two fungi to understand their lifestyles.
A total of 5,601 genes were annotated by Gene Ontology database, which include 1,562, 4,931 or 3,437 genes related to cellular components, molecular functions or biological processes, respectively (Fig. S4 ). Significant numbers of genes were found to be associated with cell/cell part/organelle/membrane (cellular component), binding/catalytic activity (molecular function), and metabolic process/cellular process (biological process). Meanwhile, a total of 6,460 genes were classified into the pathways by the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, which were further classified into the metabolic pathways (1,753 genes), and the pathways related to genetic information processing (951), environmental information processing (576), cellular processes (852), organismal systems (1,011) and diseases (1,317) ( Fig. S5 ). A significant number of genes (465) were related to carbohydrate and glycan metabolisms, including 37 genes for glycolysis/gluconeogenesis and 48 genes for N-glycan biosynthesis, suggesting these genes to be heavily utilized for the survival of the fungus.
Polysaccharides, which account for over 90% of fungal cell walls, are predominantly β-glucans, with the interchain composed of mainly β-1,3and 3-4% β-1,6-glucosidic linkages 43 . There are two identifiers for the search of β-glucan synthase (EC 2.4.1.34), Glucan_synthase (PF02364) and FKS1_dom1 (PF14288), and two GT families including β-glucan synthase, GT2 and GT48, in the CAZy database. The database search resulted in the identification of two potential genes for β-glucan synthase, ScrFKS1 and ScrFKS2 (Figs 5 and S2), which are likely the genes for type I and type II genes characteristic to Agaricomycetes mushrooms 22 , respectively. Although the details are not yet known, there two types may have differences in catalytic activity and function in different developmental stages 22 . There are significant similarities in domains and motifs between ScrFKS1 and ScrFKS2 (see Fig. 5b ), where we observed conservation of transmembrane domains, the catalytic FKS1 domain and N-glycosylation sites.
Hot water extraction of S. crispa powder resulted in the yield of β-glucan to be 50.6% 32 , although the activity of rapid estrogenic signaling through Erk1/2 and Akt was detected in the fraction of low β-glucan contents (Fig. 6c ). The same extract revealed expression profiles similar to those after the treatment with E 2 (Fig. 6d ), suggesting the activity to be estrogenic. However, the extract failed to promote cell proliferation (Fig. 6a) , thereby categorizing the activity to be that by silent estrogens. Silent estrogens are a group of chemicals with estrogenic gene-expression profiles but lacking estrogen-induced cell proliferation 28 , and include chemicals such as brefeldin A 30 and capsaicin 44 , and the mixtures of chemicals, such as the degradation product of crude oil 45 . While phenolics are supposed to have a main structural characteristic for estrogenic chemicals, there are a number of exceptions in the structure responsible for the activity 26 , enlarging the potential of activities other than the promotion of cell proliferation, and the chemicals with such a characteristic would form a quite important category of bioactive materials.
Materials and Methods
Materials. S. crispa powder was prepared from mycelia of S. crispa, strain Scrmy26, which was supplied by Intertrade Co., LTD. The genomic DNA of S. crispa was prepared with a NucleoBond buffer Set III kit (Macherey-Nagel, Düren, Germany). The DNA library for genome sequencing was constructed with 28 μg of purified DNA with the SMRTbell Template Preparation Kit 1.0 and DNA/Polymerase Binding Kit P6 (Pacific Biosciences; Menlo Park, CA). DNA sequencing and genome assembly. The S. crispa genome was sequenced by Hokkaido System Science Co., Ltd. (Sapporo, Japan), using 16 SMRT cells on the PacBio RSII platform (Pacific Biosciences) with P6-C4 chemistry, generating 21.3 Gbp (>500 × coverage). The mean, N50, and the longest insert read length of the generated data were 9,616 bp, 13,871 bp and 52,687 bp, respectively. The obtained reads were assembled using Falcon pipeline with slight modifications to the predefined parameter set distributed by the developers 46 . The assembled contigs were polished using the Arrow algorithm in the GenomicConsensus software package (https://github.com/PacificBiosciences/GenomicConsensus). The genome sequence data are available in the DDBJ BioProject Database of the DNA Database of Japan (DDBJ: http://www.ddbj.nig.ac.jp/) under Accession No. BFAD01000001-BFAD01000032 (PRJDB5582).
rRNA and tRNA identification. rRNAs were identified by Barrnap (https://github.com/tseemann/barrnap), a ribosomal RNA predictor. tRNAscan-SE 47 was used to detect tRNA regions and secondary structures.
Gene expression analysis.
A cDNA library was prepared from the total RNA using the TruSeq Stranded mRNA Sample Prep Kit (Illumina, San Diego, CA), and subjected to sequencing on the Illumina HiSeq 2500 platform. Approximately 80 million reads were obtained and used for genome annotation and gene expression analysis. The expression level of each gene was quantified by FPKM (expected fragments per kilobase of transcript per million fragments sequenced) values using Cufflinks 48 software as follows. After adapter sequences were removed from RNA-seq reads using CutAdapt 49 , the primary contigs of the assembly were mapped using TopHat2 50 . Finally, the mapped reads were counted for each gene model and reported in FPKM using Cufflinks.
Protein-coding gene prediction and functional annotation. The prediction of protein-coding genes along with their functional annotation was assisted by GeneBay Inc. (Yokohama, Japan). The RNA-seq reads were first aligned to the reference genome with HISAT 51 , then assembled by StringTie 52 to construct transcript sequences. The obtained 15,184 transcripts were used to train AUGUSTUS 53 for parameters of gene models in S. crispa. AUGUSTUS was run with exon and intron hints, derived from RNA-seq mapping data, as input data.
On the other hand, CodingQuarry 54 , which was developed to accurately predict genes in fungal genomes, was used to predict gene models using the above StringTie-derived transcript sequences. The gene models predicted by AUGUSTUS, CodingQuarry and StringTie were combined to construct 13,156 consensus gene models using EvidenceModeler 55 . All of the predicted gene models were functionally annotated based on the similarity to annotated genes. BLASTP 56 was used to align the protein sequences to Nr and fungal taxonomic divisions of Swiss-Prot 57 protein databases with an e-value < 1e-5.
Phylogenetic analysis.
A total of 26 fungal species assigned to Basidiomycota or Ascomycota, including S.
crispa, were used in the phylogenetic analysis. Their protein sequences were compared by BLASTP (e-value < 1e-5 and hit number < 500). The BLASTP result was then analyzed by OrthoMCL 58 with default parameters to find orthologous genes, where a total of 895 single-copy orthologous genes were determined. The sequence alignments of these 895 genes were calculated by MAFFT v7.309 59 , and then combined into a long sequence for each species. The conserved blocks of the alignment were selected by Gblocks 0.91b 60 with the default parameters. Finally, the phylogenetic tree was constructed by RAxML-8.2.9 61 with bootstrap 1000. The fossil calibration was done as described 62 Preparation of S. crispa mycelial extracts. The aqueous extract of S. crispa mycelia (SCE) was prepared by boiling 50 g of the S. crispa powder in 1,000 ml of Milli-Q water for 10 min. The aqueous fraction was recovered by centrifugation at 3,300 × g for 25 min and sterilized by filtration through 0.22-μm filters (Millipore; Billerica, MA). To prepare the ethylacetate fraction (SCE-EtOAc), 100 ml of 10 mg/ml SCE was mixed with 100 ml of ethylacetate, and SCE-EtOAc was recovered as the upper fraction after centrifugation at 7,000 × g for 10 min. SCE-EtOAc was then dried by evaporation. The dried material dissolved in methanol was centrifuged at 3,300 × g for 10 min at 25 °C to remove debris, and the final concentration was adjusted to 10 mg/ml.
Western blotting. MCF-7 cells were obtained from the JCRB Cell Bank (National Institute of Health Sciences, Tokyo, Japan), and cultured in RPMI 1640 (Invitrogen, Carlsbad, CA) medium supplemented with 10% fetal bovine serum (FBS) at 37 °C in 5% CO 2 . Western blotting was performed according to the protocol described in Dong et al. 30 . Phospho-Erk1/2 (P-Erk1/2) and phospho-Akt (P-Akt) were used as the primary antibodies, and rabbit antibodies against total Erk1/2 (T-Erk1/2), P-Erk1/2, total Akt (T-Akt) or P-Akt (Cell Signaling Technologies, Ipswich, MA) were used as the secondary antibodies after appropriate dilutions (1:200 to 1:1000). The antibody-antigen complexes were detected with horseradish peroxidase-coupled goat antibody against rabbit IgG (Cell Signaling Technologies) after dilution (1:3,000), and then visualized using the ECL-plus Western Blotting Detection System (Amersham Pharmacia Biotech, Arlington Heights, IL).
Cell proliferation assay. The cell proliferation assay was performed as described in Dong et al. 30 .
MCF-7 cells were cultured in phenol red-free RPMI 1640 medium supplemented with 10% dextran-coated charcoal-treated fetal bovine serum (DCC-FBS, Invitrogen) in 24-well plates. The cells were treated with 10 nM E 2 (17 β-estradiol) or the extracts under the indicated concentrations for 3 days. The cells were then fixed with 10% cold trichloroacetic acid (TCA) at 4 °C for 30 min and stained with 0.4% sulforhodamine B (SRB) dissolved in 1% acetic acid for 20 min. The bound protein was solubilized with 10 nM unbuffered Tris-base and subjected to measurement of OD 490 . Six independent assays were performed for each treatment and the data were analyzed by the t-test.
DNA microarray assay. MCF-7 cells were maintained in phenol red-free RPMI 1640 medium containing 10% DCC-FBS, and incubated for 3 days at 37 °C in 5% CO 2 . Aliquots of E 2 (10 nM), SCE (10 or 100 μg/ml) or SCE-EtOAc (10 μg/ml) in 0.1% DMSO were added to the medium, and the cells were cultured for 3 days. Cells treated with 0.1% DMSO (vehicle) were used as a control. RNA preparation and cDNA labeling followed by focused oligonucleotide-DNA microarray assays were performed as described previously 27, 70 . The values obtained were normalized and log 2 -transformed, and then used for correlation analysis. A coefficient of correlation between gene expression profiles was calculated based on linear regression using SPSS 12.0J (SPSS Japan; Tokyo, Japan). We here used a total of 150 genes selected as highly reproducible estrogen-responsive genes as described before 27 . The microarray data are available in the Gene Expression Omnibus database of the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/geo/) under Accession No. GSE108549.
